You are currently viewing The Catalysts to Advance the Interventional Glaucoma Revolution: iDose TR (travoprost intracameral implant) 75 mcg and iStent infinite

The Catalysts to Advance the Interventional Glaucoma Revolution: iDose TR (travoprost intracameral implant) 75 mcg and iStent infinite

Friday, April 5, 2024

Registration and Lunch: 11:30 am – 12:00 pm

Program: 12:00 pm – 1:00 pm

Boston, Massachusetts, USA

Boston Convention & Exhibition Center

Room 252AB

EyeWorld Corporate Events

Sponsored by Glaukos

This program is non-CME.

Glaukos is a registered trademark of Glaukos Corporation.

All rights reserved. © 2024

Moderator

Ike
Ahmed, MD

Faculty

Sahar
Bedrood, MD, PhD

John
Berdahl, MD

Manjool
Shah, MD

Blake
Williamson, MD

Register for this event